Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma.
Goedegebuure RSA, Harrasser M, de Klerk LK, van Schooten TS, van Grieken NCT, Eken M, Grifhorst MS, Pocorni N, Jordanova ES, van Berge Henegouwen MI, Pouw RE, Verheul HMW, van der Vliet JJ, van Laarhoven HWM, Thijssen VLJL, Bass AJ, De Gruijl TD, Derks S.
Goedegebuure RSA, et al. Among authors: van der vliet jj.
Oncoimmunology. 2021 Aug 4;10(1):1954807. doi: 10.1080/2162402X.2021.1954807. eCollection 2021.
Oncoimmunology. 2021.
PMID: 34377591
Free PMC article.